Language selection

Search

Patent 3188923 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 3188923
(54) English Title: METHODS FOR PRODUCING CLINICAL-GRADE LENTIVIRAL VECTOR
(54) French Title: PROCEDES DE PRODUCTION DE VECTEUR LENTIVIRAL DE QUALITE CLINIQUE
Status: Application Compliant
Bibliographic Data
(51) International Patent Classification (IPC):
  • C12N 9/22 (2006.01)
  • C12N 15/86 (2006.01)
(72) Inventors :
  • BURNHAM, MICHAEL SEAN (United States of America)
  • RAHIMIAN, MARYAM (United States of America)
(73) Owners :
  • TMUNITY THERAPEUTICS INC.
(71) Applicants :
  • TMUNITY THERAPEUTICS INC. (United States of America)
(74) Agent: MARKS & CLERK
(74) Associate agent:
(45) Issued:
(86) PCT Filing Date: 2021-08-12
(87) Open to Public Inspection: 2022-02-17
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/US2021/045677
(87) International Publication Number: WO 2022036048
(85) National Entry: 2023-02-09

(30) Application Priority Data:
Application No. Country/Territory Date
63/065,225 (United States of America) 2020-08-13

Abstracts

English Abstract

Described are improved methods for manufacturing and purifying clinical-grade retroviral vectors, such as lentiviral vectors.


French Abstract

L'invention concerne des procédés améliorés de fabrication et de purification de vecteurs rétroviraux de qualité clinique, tels que des vecteurs lentiviraux.

Claims

Note: Claims are shown in the official language in which they were submitted.

Sorry, the claims for patent document number 3188923 were not found.
Text is not available for all patent documents. The current dates of coverage are on the Currency of Information  page

Description

Note: Descriptions are shown in the official language in which they were submitted.

Sorry, the description for patent document number 3188923 was not found. Text is not available for all patent documents. The current dates of coverage are on the Currency of Information  page

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Maintenance Fee Payment Determined Compliant 2024-08-12
Maintenance Request Received 2024-08-12
Letter Sent 2023-03-27
Compliance Requirements Determined Met 2023-03-25
Inactive: IPC assigned 2023-02-09
Inactive: IPC assigned 2023-02-09
Inactive: First IPC assigned 2023-02-09
Application Received - PCT 2023-02-09
Priority Claim Requirements Determined Compliant 2023-02-09
National Entry Requirements Determined Compliant 2023-02-09
Request for Priority Received 2023-02-09
Letter sent 2023-02-09
Application Published (Open to Public Inspection) 2022-02-17

Abandonment History

There is no abandonment history.

Maintenance Fee

The last payment was received on 

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
MF (application, 2nd anniv.) - standard 02 2023-08-14 2023-02-09
Registration of a document 2023-02-09
Basic national fee - standard 2023-02-09
MF (application, 3rd anniv.) - standard 03 2024-08-12 2024-08-12
MF (application, 4th anniv.) - standard 04 2025-08-12
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
TMUNITY THERAPEUTICS INC.
Past Owners on Record
MARYAM RAHIMIAN
MICHAEL SEAN BURNHAM
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Representative drawing 2023-07-04 1 24
Cover Page 2023-07-04 1 51
Description 2023-02-09 30 1,556
Drawings 2023-02-09 3 119
Claims 2023-02-09 4 115
Abstract 2023-02-09 1 5
Confirmation of electronic submission 2024-08-12 1 60
Courtesy - Certificate of registration (related document(s)) 2023-03-27 1 351
Assignment 2023-02-09 4 161
National entry request 2023-02-09 9 200
Patent cooperation treaty (PCT) 2023-02-09 1 64
Declaration 2023-02-09 1 13
Courtesy - Letter Acknowledging PCT National Phase Entry 2023-02-09 2 49
Declaration 2023-02-09 1 14
Patent cooperation treaty (PCT) 2023-02-09 2 81
International search report 2023-02-09 4 121